2.20
price up icon2.80%   0.06
after-market Handel nachbörslich: 2.22 0.02 +0.91%
loading
Schlusskurs vom Vortag:
$2.14
Offen:
$2.14
24-Stunden-Volumen:
830.49K
Relative Volume:
1.73
Marktkapitalisierung:
$94.57M
Einnahmen:
$51.13M
Nettoeinkommen (Verlust:
$-93.80M
KGV:
-0.9865
EPS:
-2.23
Netto-Cashflow:
$-129.10M
1W Leistung:
+2.33%
1M Leistung:
+33.33%
6M Leistung:
+49.97%
1J Leistung:
+24.29%
1-Tages-Spanne:
Value
$2.13
$2.22
1-Wochen-Bereich:
Value
$2.13
$2.22
52-Wochen-Spanne:
Value
$0.89
$2.30

Repare Therapeutics Inc Stock (RPTX) Company Profile

Name
Firmenname
Repare Therapeutics Inc
Name
Telefon
(857) 412-7018
Name
Adresse
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Name
Mitarbeiter
129
Name
Twitter
@reparerx
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
RPTX's Discussions on Twitter

Vergleichen Sie RPTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RPTX
Repare Therapeutics Inc
2.20 91.99M 51.13M -93.80M -129.10M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.71 114.69B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
752.62 77.91B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
850.95 54.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
391.50 52.52B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
196.92 42.02B 447.02M -1.18B -906.14M -6.1812

Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-06-09 Hochstufung Stifel Hold → Buy
2023-02-03 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-01-06 Eingeleitet CapitalOne Overweight
2022-04-12 Herabstufung Stifel Buy → Hold
2022-03-17 Fortgesetzt Goldman Buy
2021-09-23 Eingeleitet Stifel Buy
2021-09-13 Eingeleitet H.C. Wainwright Buy
2021-06-28 Eingeleitet Guggenheim Buy
2021-03-01 Eingeleitet Berenberg Buy
2020-10-28 Eingeleitet Northland Capital Outperform
2020-07-14 Eingeleitet Cowen Outperform
2020-07-14 Eingeleitet Goldman Neutral
2020-07-14 Eingeleitet Morgan Stanley Overweight
2020-07-14 Eingeleitet Piper Sandler Overweight
Alle ansehen

Repare Therapeutics Inc Aktie (RPTX) Neueste Nachrichten

pulisher
04:46 AM

Repare Therapeutics Announces Shareholder Meeting for Acquisition Approval - TipRanks

04:46 AM
pulisher
Dec 08, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Dec 08, 2025
pulisher
Dec 06, 2025

Repare Therapeutics (RPTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 06, 2025
pulisher
Dec 04, 2025

Levels Update: Will Repare Therapeutics Inc. stock gain from lower inflation2025 AllTime Highs & Expert Verified Movement Alerts - moha.gov.vn

Dec 04, 2025
pulisher
Dec 03, 2025

Will Repare Therapeutics Inc. stock deliver strong dividend growth2025 Momentum Check & Risk Adjusted Swing Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc ( - GlobeNewswire

Dec 02, 2025
pulisher
Nov 29, 2025

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerRPTX, AXTA, WTG and SEMR - Eastern Progress

Nov 29, 2025
pulisher
Nov 28, 2025

Risk Report: Why Repare Therapeutics Inc. stock is in analyst buy zone2025 Price Momentum & Daily Price Action Insights - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights - Sahm

Nov 28, 2025
pulisher
Nov 27, 2025

Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire

Nov 27, 2025
pulisher
Nov 27, 2025

Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Nov 27, 2025
pulisher
Nov 27, 2025

Fed Watch: Is Repare Therapeutics Inc. stock a top pick in earnings seasonPortfolio Gains Report & Growth Focused Entry Reports - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

BIOTECHNOLOGY VALUE FUND L P Increases Stake in Repare Therapeutics Inc - GuruFocus

Nov 25, 2025
pulisher
Nov 23, 2025

Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Nov 23, 2025
pulisher
Nov 22, 2025

Repare shareholders vote in favor of Xeno bid - The Pharma Letter

Nov 22, 2025
pulisher
Nov 21, 2025

Repare Therapeutics Inc. (RPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 20, 2025

Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - Investing News Network

Nov 20, 2025
pulisher
Nov 20, 2025

Repare signs support agreements with key shareholders for Xenotherapeutics deal - marketscreener.com

Nov 20, 2025
pulisher
Nov 20, 2025

Repare Therapeutics (RPTX) secures 40% shareholder support for XenoTherapeutics deal - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Repare Therapeutics Inc (RPTX) looking to reclaim success with recent performance - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Why hedge funds are buying Repare Therapeutics Inc. stockJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Repare Therapeutics Reports Positive Q3 2025 Results - TipRanks

Nov 19, 2025
pulisher
Nov 19, 2025

Can Repare Therapeutics Inc. stock rebound after recent weaknessQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Update & Expert Curated Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Repare Therapeutics Inc. stock could rally in 2025Index Update & Risk Controlled Swing Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Smart tools for monitoring Repare Therapeutics Inc.’s price action2025 Momentum Check & Smart Money Movement Tracker - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

TD Cowen Downgrades Repare Therapeutics (NASDAQ:RPTX) to Hold - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Risk adjusted return profile for Repare Therapeutics Inc. analyzedRisk Management & Technical Pattern Alert System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying chart zones and confluence areas to Repare Therapeutics Inc.July 2025 Snapshot & Daily Entry Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve

Nov 18, 2025
pulisher
Nov 18, 2025

Candlestick signals on Repare Therapeutics Inc. stock todayJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX) - MarketBeat

Nov 18, 2025
pulisher
Nov 18, 2025

Repare Therapeutics Target of Unusually Large Options Trading (NASDAQ:RPTX) - Defense World

Nov 18, 2025
pulisher
Nov 17, 2025

Repare Therapeutics Announces Acquisition by XenoTherapeutics - MSN

Nov 17, 2025
pulisher
Nov 17, 2025

Real time scanner hits for Repare Therapeutics Inc. explainedJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An - GlobeNewswire

Nov 17, 2025
pulisher
Nov 17, 2025

Repare Therapeutics Gains Attention Amid Acquisition Buzz - StocksToTrade

Nov 17, 2025
pulisher
Nov 17, 2025

Cambridge-Montreal biotech Repare Therapeutics to be acquired by XenoTherapeutics - The Business Journals

Nov 17, 2025
pulisher
Nov 17, 2025

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025 - ts2.tech

Nov 17, 2025
pulisher
Nov 17, 2025

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - inkl

Nov 17, 2025
pulisher
Nov 17, 2025

Repare Therapeutics Unveils Phase 1 LIONS Trial Data - MSN

Nov 17, 2025
pulisher
Nov 17, 2025

[8-K] Repare Therapeutics Inc. Reports Material Event | RPTX SEC FilingForm 8-K - Stock Titan

Nov 17, 2025

Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.53
price up icon 0.36%
$98.64
price up icon 3.39%
$31.57
price up icon 0.83%
$93.81
price down icon 1.05%
biotechnology ONC
$310.67
price down icon 2.63%
$196.92
price down icon 0.05%
Kapitalisierung:     |  Volumen (24h):